Opaleye Management Inc. Q3 2017 Filing

Filed November 14, 2017

Portfolio Value

$282.8M

Holdings

34

Report Date

Q3 2017

Filing Type

13F-HR

All Holdings (34 positions)

#StockSharesValue% PortfolioType
1
2L9BLUEPRINT MEDICINES
735,000$51.2M18.11%
2
AXGNAXOGEN INC
1,970,000$38.1M13.48%
3
FGENEURFIBROGEN INC
360,000$19.4M6.85%
4
IMMUNOMEDICS INC
898,800$12.6M4.44%
5
LOXO ONCOLOGY
130,000$12.0M4.23%
6
CDXSCODEXIS INC
1,700,600$11.3M4.00%
7
CORIUM INTERNATIONAL INC
920,000$10.2M3.60%
8
MOMENTA PHARMACEUTICALS INC
500,000$9.3M3.27%
9
GBYSANGAMO BIOSCIENCES INC
580,000$8.7M3.08%
10
AGIOAGIOS PHARMACEUTICALS
130,000$8.7M3.07%
11
CTMXCYTOMX THERAPEUTICS INC
450,000$8.2M2.89%
12
STRONGBRIDGE BIOPHARMA PLC
1,180,000$8.1M2.88%
13
EGRXEAGLE PHARMACEUTICALS INC
130,000$7.8M2.74%
14
CMRXEURCHIMERIX INC
1,403,000$7.4M2.60%
15
FOAMIX PHARMACEUTICALS LTD
1,142,000$6.3M2.24%
16
XOMAXOMA CORP DEL
320,200$6.3M2.23%
17
TBPHTHERAVANCE BIOPHARMA INC
180,000$6.2M2.18%
18
CBAYUSDCYMABAY THERAPEUTICS INC
665,000$5.4M1.89%
19
AUDENTES THERAPEUTICS INC
180,000$5.0M1.78%
20
SYNLOGIC INC
250,000$4.8M1.68%
21
ENTAENANTA PHARMACEUTICALS INC
100,000$4.7M1.66%
22
DCPHEURDECIPHERA PHARMACEUTICALS INC
217,000$4.1M1.46%
23
ARDXARDELYX
700,000$3.9M1.39%
24
XLRNACCELERON PHARMA INC
101,500$3.8M1.34%
25
IM8NINSMED INC
120,000$3.7M1.32%
26
INOTEK PHARMACEUTICALS CORP
1,802,000$3.2M1.13%
27
NEURODERM LTD
70,000$2.7M0.96%
28
ARATANA THERAPEUTICS INC
420,000$2.6M0.91%
29
SELBUSDSELECTA BIOSCIENCES INC
95,000$1.7M0.61%
30
SYROS PHARMACEUTICALS INC
116,574$1.7M0.61%
31
ICPTUSDINTERCEPT PHARMACEUTICALS INC
28,400$1.6M0.58%
32
ARQULE INC
1,220,000$1.4M0.48%
33
QUOTUSDQUOTIENT TECHNOLOGY INC
110,000$542K0.19%
34
BIOLINERX LTD
250,000$280K0.10%